MedicineWatch US
Class III Recall

Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.

Product
Abilify (aripiprazole), 30 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-011-13
Reason
Cross Contamination with Other Products
Classification
Class III
Status
Ongoing
Lot
Lot # APS00423A, Exp 07/31/2025; APS00222A, Exp 11/30/2024
Date
Disclaimer: This tool indexes published US FDA drug-enforcement recall records from all countries, limited to the latest five years. A company or product not appearing here is not proof that it is compliant, approved, safe, or free of FDA action.